Solid Biosciences (SLDB) Leases: 2019-2024
Historic Leases for Solid Biosciences (SLDB) over the last 6 years, with Sep 2024 value amounting to $24.9 million.
- Solid Biosciences' Leases fell 8.57% to $24.9 million in Q3 2024 from the same period last year, while for Sep 2024 it was $24.9 million, marking a year-over-year decrease of 8.57%. This contributed to the annual value of $26.5 million for FY2023, which is 8.32% down from last year.
- Per Solid Biosciences' latest filing, its Leases stood at $24.9 million for Q3 2024, which was down 2.54% from $25.5 million recorded in Q2 2024.
- In the past 5 years, Solid Biosciences' Leases ranged from a high of $28.9 million in Q4 2022 and a low of $722,000 during Q1 2022.
- For the 3-year period, Solid Biosciences' Leases averaged around $24.9 million, with its median value being $27.2 million (2023).
- Per our database at Business Quant, Solid Biosciences' Leases tumbled by 77.41% in 2022 and then surged by 3,820.50% in 2023.
- Solid Biosciences' Leases (Quarterly) stood at $3.6 million in 2020, then plummeted by 68.09% to $1.1 million in 2021, then spiked by 2,434.94% to $28.9 million in 2022, then decreased by 8.32% to $26.5 million in 2023, then declined by 8.57% to $24.9 million in 2024.
- Its Leases was $24.9 million in Q3 2024, compared to $25.5 million in Q2 2024 and $26.1 million in Q1 2024.